Michael Pokrass

1.1k total citations · 1 hit paper
10 papers, 822 citations indexed

About

Michael Pokrass is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Pokrass has authored 10 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Pokrass's work include Virus-based gene therapy research (3 papers), CRISPR and Genetic Engineering (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Michael Pokrass is often cited by papers focused on Virus-based gene therapy research (3 papers), CRISPR and Genetic Engineering (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Michael Pokrass collaborates with scholars based in United States and Germany. Michael Pokrass's co-authors include Sergi Regot, Francisca Rojas, Ki‐Jun Yoon, Peng Jin, Guo‐li Ming, Xinyuan Wang, Yijing Su, Nam-Shik Kim, Louis C. Doré and Stefan Canzar and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Cancer Research.

In The Last Decade

Michael Pokrass

8 papers receiving 817 citations

Hit Papers

Temporal Control of Mammalian Cortical Neurogenesis by m6... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Pokrass United States 6 729 219 83 70 61 10 822
Mathilde Cheray France 17 561 0.8× 200 0.9× 77 0.9× 22 0.3× 18 0.3× 29 853
Mariana D. Mandler United States 7 697 1.0× 217 1.0× 26 0.3× 18 0.3× 22 0.4× 9 813
Jiahang Sun China 12 362 0.5× 223 1.0× 14 0.2× 67 1.0× 19 0.3× 30 530
Fen Nie China 11 465 0.6× 73 0.3× 25 0.3× 71 1.0× 41 0.7× 16 597
Bingquan Lai China 9 333 0.5× 152 0.7× 18 0.2× 83 1.2× 54 0.9× 11 475
Yasna Contreras‐Baeza Chile 8 305 0.4× 94 0.4× 7 0.1× 141 2.0× 33 0.5× 8 459
Zachary M. March United States 9 727 1.0× 337 1.5× 12 0.1× 47 0.7× 47 0.8× 9 852
Erik McShane United States 18 675 0.9× 73 0.3× 115 1.4× 93 1.3× 142 2.3× 34 952
Delphine Larrieu United Kingdom 11 744 1.0× 89 0.4× 8 0.1× 32 0.5× 101 1.7× 16 870
Hugh Nuthall United Kingdom 17 516 0.7× 21 0.1× 19 0.2× 80 1.1× 41 0.7× 29 769

Countries citing papers authored by Michael Pokrass

Since Specialization
Citations

This map shows the geographic impact of Michael Pokrass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pokrass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pokrass more than expected).

Fields of papers citing papers by Michael Pokrass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pokrass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pokrass. The network helps show where Michael Pokrass may publish in the future.

Co-authorship network of co-authors of Michael Pokrass

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pokrass. A scholar is included among the top collaborators of Michael Pokrass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pokrass. Michael Pokrass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kato, Yu, Michael Pokrass, Jinkil Jeong, et al.. (2024). Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment. Communications Biology. 7(1). 1132–1132. 3 indexed citations
2.
Pokrass, Michael, et al.. (2023). Abstract 681: ICVB-1042, an oncolytic adenovirus, infects and kills bladder, breast, and glioblastoma human dissociated tumor cells. Cancer Research. 83(7_Supplement). 681–681. 1 indexed citations
3.
Pokrass, Michael, et al.. (2022). 1216 The chimeric Ad5/Ad34 fiber of ICVB-1042 oncolytic virus requires the CD46 cell surface receptor for efficient tumor entry. Regular and Young Investigator Award Abstracts. A1261–A1261. 1 indexed citations
4.
Pokrass, Michael & Sergi Regot. (2021). 3D time-lapse microscopy paired with endpoint lineage analysis in mouse blastocysts. STAR Protocols. 2(2). 100446–100446. 2 indexed citations
5.
Pokrass, Michael, Kathleen A. Ryan, Tianchi Xin, et al.. (2020). Cell-Cycle-Dependent ERK Signaling Dynamics Direct Fate Specification in the Mammalian Preimplantation Embryo. Developmental Cell. 55(3). 328–340.e5. 62 indexed citations
6.
Peterson, Amy, et al.. (2020). MAPK activity dynamics regulate non-cell autonomous effects of oncogene expression. eLife. 9. 60 indexed citations
7.
Yoon, Ki‐Jun, Francisca Rojas, Caroline Vissers, et al.. (2017). Temporal Control of Mammalian Cortical Neurogenesis by m6A Methylation. Cell. 171(4). 877–889.e17. 551 indexed citations breakdown →
8.
Tsai, Shang‐Yi, et al.. (2015). Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid. Proceedings of the National Academy of Sciences. 112(21). 6742–6747. 64 indexed citations
9.
Tsai, Shang‐Yi, et al.. (2014). Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders. Expert Opinion on Therapeutic Targets. 18(12). 1–16. 63 indexed citations
10.
Pokrass, Michael, et al.. (2013). Activation of complement by monoclonal antibodies that target cell-associated β2-microglobulin: Implications for cancer immunotherapy. Molecular Immunology. 56(4). 549–560. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026